Pimonidazole binding in C6 rat brain glioma: relation with lipid droplet detection.
In C6 rat brain glioma, we have investigated the relation between hypoxia and the presence of lipid droplets in the cytoplasm of viable cells adjacent to necrosis. For this purpose, rats were stereotaxically implanted with C6 cells. Experiments were carried out by the end of the tumour development. A multifluorescence staining protocol combined with digital image analysis was used to quantitatively study the spatial distribution of hypoxic cells (pimonidazole), blood perfusion (Hoechst 33342), total vascular bed (collagen type IV) and lipid droplets (Red Oil) in single frozen sections. All tumours (n=6) showed necrosis, pimonidazole binding and lipid droplets. Pimonidazole binding occurred at a mean distance of 114 microm from perfused vessels mainly around necrosis. Lipid droplets were principally located in the necrotic tissue. Some smaller droplets were also observed in part of the pimonidazole-binding cells surrounding necrosis. Hence, lipid droplets appeared only in hypoxic cells adjacent to necrosis, at an approximate distance of 181 microm from perfused vessels. In conclusion, our results show that severe hypoxic cells accumulated small lipid droplets. However, a 100% colocalisation of hypoxia and lipid droplets does not exist. Thus, lipid droplets cannot be considered as a surrogate marker of hypoxia, but rather of severe, prenecrotic hypoxia.
Zoula
S
S
Laboratoire Mixte INSERM U438 RMN Bioclinique, Université Joseph Fourier, Centre Hospitalier Universitaire Pavillon B, BP 217, 38043 Grenoble Cedex 09, France.
Rijken
P F J W
PF
Peters
J P W
JP
Farion
R
R
Van der Sanden
B P J
BP
Van der Kogel
A J
AJ
Décorps
M
M
Rémy
C
C
D000818:Animals; D001921:Brain / Q000098:blood supply / Q000378:metabolism* / Q000473:pathology; D015687:Cell Hypoxia; D005910:Glioma / Q000098:blood supply / Q000378:metabolism* / Q000473:pathology; D007150:Immunohistochemistry; D008055:Lipids / Q000032:analysis; D008833:Microcirculation / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000473:pathology; D009593:Nitroimidazoles / Q000493:pharmacokinetics*; D011838:Radiation-Sensitizing Agents / Q000493:pharmacokinetics; D051381:Rats
D008055:Lipids; D009593:Nitroimidazoles; D011838:Radiation-Sensitizing Agents; C033815:pimonidazole